Update, 1:42 p.m. ET, November 16, 2026: Anthropic’s IPO remains scheduled to price on November 18, with Nasdaq trading targeted for November 19. The company has not announced a final offer price. Fidelity says its indication-of-interest window is expected to close at 4:00 p.m. ET on November 17, while Reuters reported strong institutional demand during last week’s roadshow.
Anthropic (proposed NASDAQ: ANT), the developer of Claude, is preparing to sell 825 million shares at an indicative $70 to $78 each. That puts the proposed public offering at $57.75 billion to $64.35 billion before any underwriters’ option. For individual investors, the critical questions are whether they can obtain an IPO allocation, what valuation they would be paying, and whether Claude’s revenue growth can justify the company’s long-term compute spending.
Anthropic began its IPO roadshow on November 10 and applied to list its Class A shares on the Nasdaq Global Select Market under ANT. The company’s roadshow announcement and November 10 SEC prospectus establish the preliminary terms.
| IPO detail | Current plan |
|---|---|
| Proposed ticker | ANT, Nasdaq |
| Indicative offer price | $70 to $78 per share |
| Shares in public offering | 825,000,000 |
| Shares sold by Anthropic | 801,351,354 |
| Shares sold by existing holders | 23,648,646 |
| Expected final pricing | November 18, 2026 |
| Expected first Nasdaq trading | November 19, 2026 |
| Lead underwriters | Goldman Sachs and Morgan Stanley |
The issuer does not receive the proceeds from shares sold by existing stockholders. The prospectus also provides for an underwriters’ option to purchase up to 123.75 million additional shares. Dates and price remain subject to regulatory effectiveness and market conditions; ANT has no established public-market trading price yet.
Yes, some eligible U.S. investors can request shares before public trading, but allocation is not guaranteed. Anthropic’s IPO materials identify Charles Schwab, E*TRADE, Fidelity, Robinhood and SoFi among participating brokerage platforms. Availability and minimums differ, and an indication of interest is not a completed purchase.
Fidelity’s Anthropic-specific participation instructions say its request period is expected to end November 17 at 4:00 p.m. ET. Its minimum request is 25 shares, in 25-share increments. At the indicative range, a 25-share request corresponds to $1,750 to $1,950, although investors may receive fewer shares or none. Fidelity requires a further confirmation after pricing to remain eligible.
Investors who do not receive an allocation can consider buying ANT through an ordinary brokerage account when trading begins. The market-opening price may be above or below the IPO offer price. Compare account fees, access and order execution in our U.S. online broker comparison; the lowest advertised commission does not guarantee a favorable entry price.
How much is Anthropic valued at?
At the $74 midpoint, the 825 million public shares imply $61.05 billion of gross sales, including selling-stockholder proceeds. That figure is the size of the share sale, not Anthropic’s market value. Based on approximately 13.087 billion expected outstanding shares after the offering and concurrent placement, the proposed market capitalization is about $968.4 billion at $74, or $1.021 trillion at $78. Reuters has described a roughly $1.4 trillion fully diluted valuation at the top of the price range when additional potential shares are considered.
Using the company’s October annualized revenue run rate of approximately $81 billion, the $968.4 billion midpoint equity value represents about 12.0 times that run rate. The metric is not a trailing-12-month sales multiple: October’s annualized rate is higher than realized revenue for any full year so far. Investors should compare prices using the same share-count definition rather than treating the $1 trillion and $1.4 trillion estimates as interchangeable.
What Anthropic’s IPO financials actually show
The amended Form S-1 reports the following U.S. GAAP results for the nine months ended September 30. Dollar figures are in billions unless indicated otherwise.
| Metric | First nine months of 2026 | First nine months of 2025 | Change |
|---|---|---|---|
| Revenue | $33.242B | $2.545B | +1,206.2% |
| Compute and infrastructure expense | $18.808B | $4.381B | +329.3% |
| GAAP operating result | -$1.260B | -$5.224B | Loss narrowed |
| GAAP net loss | -$104.039B | -$25.107B | Loss widened |
| Operating cash flow | +$6.569B | -$2.024B | +$8.593B |
Revenue grew by more than 13 times, and computing costs represented approximately 56.6% of 2026 nine-month revenue, compared with about 172.1% in the comparable 2025 period. That improved operating leverage is material, but it has not yet produced consistent GAAP operating profits.
The $104.039 billion GAAP net loss requires context: $94.324 billion relates to changes in the fair value of convertible notes, derivatives and SAFEs. These are primarily noncash valuation effects, so the headline net loss should not be confused with cash consumed by day-to-day operations. Equally, $6.569 billion of positive operating cash flow is not free cash flow, and it does not fund the entire infrastructure buildout.
The $900.9 billion commitment investors cannot ignore
Anthropic discloses approximately $900.9 billion in aggregate contractual obligations, substantially all tied to compute and infrastructure, including specified purchase arrangements and leases. Roughly $70.7 billion is due in the 12 months following September 30, 2026. These are long-dated purchase and lease commitments, not $900.9 billion of immediately payable debt.
The economic risk is the gap between committed capacity and the revenue or margin that capacity produces. If model prices fall, demand disappoints or power and chip delivery is delayed, spending may remain binding even as anticipated cash inflows weaken. Our separate analysis of AI data-center financing risks explains why rapidly rising revenue and heavy infrastructure obligations can coexist.
The IPO is also accompanied by a conditional $26 billion private placement to strategic investors. This provides financing support, but it further links Anthropic’s investment case to the economics of companies supplying its infrastructure. It should not be added to the public-share count when calculating the public offering’s $57.75 billion to $64.35 billion gross sale value.
Business strengths, competition and governance
Anthropic monetizes Claude through enterprise usage, APIs and subscriptions. The prospectus says the number of customers spending at least $100,000 on a trailing-12-month basis increased from more than 950 in September 2025 to more than 11,900 in September 2026. Broader adoption could expand the use of Claude beyond coding into business analysis and workplace tools. The company’s new Claude office products illustrate that ambition, although future contribution to profits remains uncertain.
Competition remains intense across frontier models and enterprise software. Model-quality leadership can change quickly, and lower prices for AI inference would pressure Anthropic unless operating efficiency improves enough to offset the decline. This matters more for prospective shareholders than a temporary surge in IPO subscriptions. Reuters reported on November 13 that the deal was about six times subscribed by Thursday, while investors still questioned the durability of its advantage.
Governance is another unusual trade-off. Anthropic is a Delaware public benefit corporation. Under its proposed structure, a founder-controlled Class F share carries 50.1% of voting power on matters put to shareholders generally, while its Long-Term Benefit Trust elects a majority of the board. Public Class A investors will own economic interests but have limited ability to redirect the company’s strategy through ordinary shareholder voting.
Should you buy ANT at the IPO price or wait?
An IPO allocation offers the possibility of paying the final offer price, not a guaranteed profit. Strong demand could make shares difficult to obtain and push the market-opening price higher, but that same premium would increase the valuation risk. A weaker opening would leave allocated buyers with an immediate paper loss.
A practical approach is to decide on a maximum acceptable valuation before trading begins, then assess the first market price against it. Investors can also wait for several sessions of price discovery and more public-company reporting. That may mean missing an early advance, but it avoids treating a high-profile allocation as a substitute for investment analysis.
Bottom line: Anthropic offers rare direct exposure to a rapidly growing frontier AI business, but the prospective valuation already assumes exceptional future execution. Retail investors should separate IPO access from investment merit and weigh revenue quality, cash conversion, governance and the $900.9 billion compute obligation before deciding what ANT is worth.
Data as of 1:42 p.m. ET, November 16, 2026. For informational purposes only; not investment advice.

